Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic Landscape of HCC
Nia Adeniji, Renumathy Dhanasekaran
Current Hepatology Reports (2020) Vol. 19, Iss. 4, pp. 448-461
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
Nia Adeniji, Renumathy Dhanasekaran
Hepatology Communications (2021) Vol. 5, Iss. 12, pp. 1972-1986
Open Access | Times Cited: 40
Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview
Raluca-Margit Szilveszter, Mara Muntean, Adrian Florea
Biomolecules (2024) Vol. 14, Iss. 6, pp. 656-656
Open Access | Times Cited: 4
Tetrahydrocurcumin-induced apoptosis of hepatocellular carcinoma cells involves the TP53 signaling pathway, as determined by network pharmacology
Zhiwei Bao, Zhang Ye, Zhaodong Liu, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access
Validation of two prognostic gene scores in patients undergoing liver resection for hepatocellular carcinoma
Saskia Maria Schnabl, Jeanett Klubien, Colm J. O’Rourke, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102544-102544
Open Access
Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Prospects and Challenges for T Cell-Based Therapies of HCC
Norman Woller, Sophie Anna Engelskircher, Thomas Wirth, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 21
Advances in the Mechanism of Luteolin against Hepatocellular Carcinoma Based on Bioinformatics and Network Pharmacology
Yunqi Han, Yunfeng Xiao, Lei Yu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 6, pp. 966-980
Open Access | Times Cited: 9
Updates on the Diagnosis and Management of Hepatocellular Carcinoma
Aimun Raees, Muhammad Kamran, Hasan Özkan, et al.
Euroasian Journal of Hepato-Gastroenterology (2021) Vol. 11, Iss. 1, pp. 32-40
Open Access | Times Cited: 18
SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
You‐Yu Lin, Wenting Zhong, Qili Lin, et al.
PubMed (2023) Vol. 13, Iss. 6, pp. 2269-2284
Closed Access | Times Cited: 7
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence
Shukui Qin, Hongming Pan, Jean Frédéric Blanc, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 2
Atractylenolide II regulates the proliferation, ferroptosis, and immune escape of hepatocellular carcinoma cells by inactivating the TRAF6/NF-κB pathway
Yujie Lin, Ke Chen, Min Zhu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7697-7710
Closed Access | Times Cited: 2
Obovatol inhibits proliferation, invasion and immune escape of hepatocellular carcinoma cells through modulating the JAK/STST3/PD-L1 pathway
Chunhong Liao, Min Zhao, Xiao Jiang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112775-112775
Closed Access | Times Cited: 2
Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma
Lingzhen Hu, Zongren Wang, Yang Liao, et al.
Oncology and Translational Medicine (2024) Vol. 10, Iss. 4, pp. 162-170
Open Access | Times Cited: 2
NIR fluorescent probe with variable lipophilicity for imaging lysosomal copper during cuproptosis in HCC cells
Ruowei Tian, Taiyu Guo, Bin Yang, et al.
Dyes and Pigments (2023) Vol. 219, pp. 111590-111590
Closed Access | Times Cited: 6
Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging
Junxiao Wang, Rui Liu, Yun Zhao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Structure of POU2AF1 recombinant protein and it affects the progression and treatment of liver cancer based on WGCNA and molecular docking analysis
Xin Li, Hongxu Zhou, Ruiyang Ma, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134629-134629
Closed Access | Times Cited: 1
DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma
Xiaochuan Zhang, Wenyu Wang, Shanshan Mo, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 6, pp. 2096-2108
Closed Access | Times Cited: 1
Hepatocellular Carcinoma Gene Expression: The New Era, Where It goes?
Nourhan Badwei
iLiver (2022) Vol. 2, Iss. 1, pp. 36-40
Open Access | Times Cited: 6
Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma
Chenhao Jiang, Zijian Liu, Jingsheng Yuan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4335-4335
Open Access | Times Cited: 3
Tanshinone I suppresses hepatocellular carcinoma cells growth through targeting DNA double-strand break repair
Zhen Qian, Nannan Feng, Anke Geng
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hypoxia-induced HIF1A activates DUSP18-mediated MAPK14 dephosphorylation to promote hepatocellular carcinoma cell migration and invasion
Jian Pu, Zebang Qin, Quan Fang, et al.
Pathology - Research and Practice (2022) Vol. 237, pp. 153955-153955
Closed Access | Times Cited: 5
Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC
Wenwen Wang, Lifen Wang, Chunxia Song, et al.
Journal of Gastrointestinal Cancer (2023) Vol. 55, Iss. 1, pp. 444-456
Open Access | Times Cited: 2
Acute-on-Chronic Liver Failure on Older Patients -an Overview
Fadhl Alzamili
Academic International Journal of Medical Sciences (2024) Vol. 2, Iss. 2, pp. 09-11
Closed Access
Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review
Hiroko Naganuma, Hideaki Ishida
Diagnostics (2023) Vol. 13, Iss. 22, pp. 3426-3426
Open Access | Times Cited: 1
Cepharanthine suppresses proliferation and metastasis and enhances apoptosis by regulating JAK2/Stat3 pathway in hepatocellular carcinoma
Yichao Liang, Jun Li, Honglin Xu, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 14, pp. 94-100
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top